Scientific article
English

Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia

Published inJournal of Alzheimer's Disease, vol. 60, no. 1, p. 273-281
Publication date2017
Abstract

Macrophage migration inhibitory factor (MIF) is a pro-inflammatory protein playing a regulatory role in the immune response. First evidence from in vitro and animal studies suggests that MIF may be involved in the development of Alzheimer's disease (AD) pathology.

Keywords
  • Aged
  • Aged, 80 and over
  • Amyloid beta-Peptides/blood/cerebrospinal fluid
  • Apolipoproteins E/genetics
  • Cognitive Dysfunction/blood/cerebrospinal fluid/genetics/physiopathology
  • Dementia/blood/cerebrospinal fluid/genetics/physiopathology
  • Female
  • Humans
  • Intramolecular Oxidoreductases/blood/cerebrospinal fluid
  • Macrophage Migration-Inhibitory Factors/blood/cerebrospinal fluid
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Peptide Fragments/blood/cerebrospinal fluid
  • Psychiatric Status Rating Scales
  • tau Proteins/blood/cerebrospinal fluid
Affiliation entities Not a UNIGE publication
Citation (ISO format)
OIKONOMIDI, Aikaterini et al. Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer’s Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia. In: Journal of Alzheimer’s Disease, 2017, vol. 60, n° 1, p. 273–281. doi: 10.3233/JAD-170335
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1387-2877
472views
0downloads

Technical informations

Creation08/06/2018 09:18:00
First validation08/06/2018 09:18:00
Update27/06/2025 11:45:45
Status update27/06/2025 11:45:45
Last indexation27/06/2025 11:47:50
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack